News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
586,090 Results
Type
Article (55185)
Company Profile (114)
Press Release (530791)
Section
Business (174077)
Career Advice (1969)
Deals (30540)
Drug Delivery (83)
Drug Development (63278)
Employer Resources (132)
FDA (14511)
Job Trends (12305)
News (287960)
Policy (25582)
Tag
Academia (2662)
Alliances (45379)
Alzheimer's disease (1190)
Approvals (14498)
Artificial intelligence (146)
Bankruptcy (262)
Best Places to Work (9724)
Breast cancer (158)
Cancer (1292)
Cardiovascular disease (100)
Career advice (1624)
Cell therapy (250)
Clinical research (49910)
Collaboration (525)
Compensation (122)
COVID-19 (2177)
C-suite (116)
Data (1218)
Diabetes (166)
Diagnostics (5517)
Drug discovery (90)
Earnings (69999)
Employer resources (109)
Events (74902)
Executive appointments (427)
FDA (15180)
Funding (460)
Gene therapy (183)
GLP-1 (611)
Government (3181)
Healthcare (15503)
Infectious disease (2263)
Inflammatory bowel disease (101)
Interviews (361)
IPO (14365)
Job creations (2927)
Job search strategy (1382)
Layoffs (345)
Legal (5434)
Lung cancer (182)
Manufacturing (197)
Medical device (11649)
Medtech (11654)
Mergers & acquisitions (16456)
Metabolic disorders (461)
Neuroscience (1498)
NextGen: Class of 2025 (5218)
Non-profit (3948)
Northern California (1405)
Obesity (264)
Opinion (188)
Patents (113)
People (47976)
Phase I (14861)
Phase II (21436)
Phase III (17295)
Pipeline (574)
Postmarket research (2316)
Preclinical (7424)
Radiopharmaceuticals (198)
Rare diseases (233)
Real estate (5206)
Regulatory (18316)
Research institute (2552)
Resumes & cover letters (312)
Southern California (1250)
Startups (2996)
United States (12956)
Vaccines (516)
Weight loss (201)
Date
Last 7 days (585)
Last 30 days (1545)
Last 365 days (29037)
2025 (1302)
2024 (29395)
2023 (33646)
2022 (44007)
2021 (47601)
2020 (45724)
2019 (39285)
2018 (29934)
2017 (29028)
2016 (28074)
2015 (33602)
2014 (26017)
2013 (22676)
2012 (23549)
2011 (24350)
2010 (22462)
Location
Africa (717)
Arizona (126)
Asia (36890)
Australia (6548)
California (3182)
Canada (1276)
China (305)
Colorado (157)
Connecticut (159)
Europe (82763)
Florida (517)
Georgia (133)
Illinois (330)
Indiana (186)
Japan (95)
Maryland (525)
Massachusetts (2268)
Michigan (173)
Minnesota (241)
New Jersey (1035)
New York (1011)
North Carolina (673)
Northern California (1405)
Ohio (134)
Pennsylvania (746)
South America (1036)
Southern California (1250)
Texas (498)
Utah (96)
Washington State (363)
586,090 Results for "zion market research".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Izotropic Featured in Announcement of Research and Markets’ U.S. Breast Cancer Analysis and Forecast
- Company listed in Research and Markets’ announcement and description of new research report on the U.S. Breast Cancer Screening and Diagnostic Market- - “U.S. breast cancer screening and diagnostic [device] market was valued at $1.55 billion in 2024 and is anticipated to reach $2.34 billion by the end of 2030, at a CAGR of 7.05% during the forecast period 2024-20301"- -Report supports Company’s regulatory strategy for IzoView Breast CT, reinforces high demand for new breast imaging modalities, strengthens the potential for rapid market adoption and significant market share -
January 17, 2025
·
8 min read
Business
Bionano Announces Software Marketing Agreement with Revvity for Newborn Sequencing Research
Bionano has entered into a software marketing agreement with Revvity, Inc. (Revvity) under which Revvity will market and commercialize Bionano’s VIA™ software to Revvity’s next generation sequencing (NGS) customers as part of its newborn sequencing research workflow.
June 20, 2024
·
5 min read
Press Releases
Viral Vector Production (Research-use) Market Size to Hit USD 7.62 Bn by 2034
December 17, 2024
·
1 min read
Career Advice
How to Negotiate Your Salary According to Market Value
In our comprehensive guide to salary negotiation, we’ll teach you what a market salary is, how to research a market value salary and, ultimately, how to negotiate your salary according to market value.
October 1, 2024
·
5 min read
·
Franklin Carpenter
Press Releases
Stem Cells Market Size to Reach USD 48.83 Billion By 2034 - Exclusive Report by Precedence Research
December 13, 2024
·
1 min read
Exosome Research Market Will Grow at a CAGR of 16.26% 2024-2031
Global Exosome Research Market is valued at US$ 172.30 Mn in 2023, and it is expected to reach US$ 570.70 Mn by 2031, with a CAGR of 16.26% during the forecast period of 2024-2031.
April 22, 2024
·
4 min read
Partnered
All About Speed: Lilly Drives Innovation With New Facility to Help Bring Medicines to Market
Eli Lilly and Company has invested more than $20 billion in its manufacturing capabilities since 2020 to help meet high demand for its medicines. Its recently announced Lilly Medicine Foundry—which will support research and development efforts—is just the latest example of the ability to research new ways of producing medicines, while also scaling up manufacturing of medicines for clinical trials.
January 6, 2025
·
5 min read
·
BioSpace Insights
Biospecimen Contract Research Services Market Worth USD 11.70 Billion to 2031
Global Biospecimen Contract Research Services Market is valued at US$ 4.38 Bn in 2023, and it is expected to reach US$ 11.70 Bn by 2031, with a CAGR of 13.37 % during the forecast period of 2024-2031.
April 30, 2024
·
4 min read
Zion Pharma Announces Global Agreement with Roche to Develop and Commercialize a Blood Brain Barrier Penetrant Oral HER2 Tyrosine Kinase Inhibitor
Zion Pharma Limited, a Chinese biotechnology company focused on the development of brain-penetrable compounds, announced that Roche has acquired the global rights to Zion’s lead program, ZN-A-1041.
May 9, 2023
·
3 min read
Press Releases
ONI Expands Horizons: Entering the Lipid Nanoparticle Research Market
September 17, 2024
·
2 min read
1 of 58,609
Next